Page 1 of 16
NSG 552 EXAM 2 PSYCHOPHARMACOLOGY
EXAM 2 WITH CORRECT ANSWERS
NEWEST MODEL 2026 EXAM VERIFIED
Psychopharmacology exam 2
The rate-limiting enzyme in the synthesis of catecholamines is
a. Tyrosine hydroxylase
b. aromatic acid decarboxylase
, Page 2 of 16
c. dopamine B- hydroxlase
d. DOPA
a. Tryosine hydroxylase
2. Activation of terminal autoreceptors inhibits dopamine release
by
a. increasing Cl- entry into the terminal.
b. decreasing Ca2+ entry into the terminal.
c. preventing reuptake into vesicles.
d. decreasing Na+ entry into the terminal.
B. Decreasing Ca 2+ entry into the terminal
3. _______ and _______ exert their pharmacological effects by
blocking monoamine reuptake.
a. Cocaine; phenelzine
b. Cocaine; tricyclic antidepressants
c. Clonidine; tricyclic antidepressants
d. Clonidine; yohimbine
B. Cocaine; tricyclic antidepressants
4. The dopamine pathway most important for regulating movement
is the _______ pathway.
a. nigrostriatal
b. mesocortical
c. mesolimbic
d. tuberohypophyseal
A. Nigrostriatal
5. A commonly used dopamine receptor agonist is _______, which
is now being used to treat _______.
a. apomorphine; schizophrenia
b. apomorphine; erectile dysfunction
, Page 3 of 16
c. haloperidol; cocaine addiction
d. quinpirole; schizophrenia
B. haloperidol; cocaine addiction
6. Dopaminergic cell bodies are found primarily in the _______,
while adrenergic cell bodies are found in the _______.
a. midbrain; pons and medulla
b. midbrain; hypothalamus
c. pons and medulla; forebrain
d. frontal cortex; cerebellum
A. midbrain; pons and medulla
7. B1- and B2-adrenoceptors _______ while B2-receptors _______.
a. stimulate adenylyl cyclase; enhance free Ca++ levels
b. inhibit adenylyl cyclase; stimulate adenylyl cyclase
c. stimulate adenylyl cyclase; inhibit adenylyl cyclase
d. increase K+ channel opening; inhibit adenylyl cyclase
c. stimulate adenylyl cyclase; inhibit adenylyl cyclase
8. In the treatment of hypertension, prazosin _______, while
propranolol _______.
a. blocks alpha1-receptors and causes dilation of blood vessels;
blocks beta-receptors in the heart and decreases the contractile
force
b. blocks alpha 1-receptors and causes constriction of blood
vessels; activates beta -receptors in the heart and increases the
contractile force
c. activates alpha 1-receptors and causes dilation of blood vessels;
activates beta-receptors in the heart and decreases the contractile
NSG 552 EXAM 2 PSYCHOPHARMACOLOGY
EXAM 2 WITH CORRECT ANSWERS
NEWEST MODEL 2026 EXAM VERIFIED
Psychopharmacology exam 2
The rate-limiting enzyme in the synthesis of catecholamines is
a. Tyrosine hydroxylase
b. aromatic acid decarboxylase
, Page 2 of 16
c. dopamine B- hydroxlase
d. DOPA
a. Tryosine hydroxylase
2. Activation of terminal autoreceptors inhibits dopamine release
by
a. increasing Cl- entry into the terminal.
b. decreasing Ca2+ entry into the terminal.
c. preventing reuptake into vesicles.
d. decreasing Na+ entry into the terminal.
B. Decreasing Ca 2+ entry into the terminal
3. _______ and _______ exert their pharmacological effects by
blocking monoamine reuptake.
a. Cocaine; phenelzine
b. Cocaine; tricyclic antidepressants
c. Clonidine; tricyclic antidepressants
d. Clonidine; yohimbine
B. Cocaine; tricyclic antidepressants
4. The dopamine pathway most important for regulating movement
is the _______ pathway.
a. nigrostriatal
b. mesocortical
c. mesolimbic
d. tuberohypophyseal
A. Nigrostriatal
5. A commonly used dopamine receptor agonist is _______, which
is now being used to treat _______.
a. apomorphine; schizophrenia
b. apomorphine; erectile dysfunction
, Page 3 of 16
c. haloperidol; cocaine addiction
d. quinpirole; schizophrenia
B. haloperidol; cocaine addiction
6. Dopaminergic cell bodies are found primarily in the _______,
while adrenergic cell bodies are found in the _______.
a. midbrain; pons and medulla
b. midbrain; hypothalamus
c. pons and medulla; forebrain
d. frontal cortex; cerebellum
A. midbrain; pons and medulla
7. B1- and B2-adrenoceptors _______ while B2-receptors _______.
a. stimulate adenylyl cyclase; enhance free Ca++ levels
b. inhibit adenylyl cyclase; stimulate adenylyl cyclase
c. stimulate adenylyl cyclase; inhibit adenylyl cyclase
d. increase K+ channel opening; inhibit adenylyl cyclase
c. stimulate adenylyl cyclase; inhibit adenylyl cyclase
8. In the treatment of hypertension, prazosin _______, while
propranolol _______.
a. blocks alpha1-receptors and causes dilation of blood vessels;
blocks beta-receptors in the heart and decreases the contractile
force
b. blocks alpha 1-receptors and causes constriction of blood
vessels; activates beta -receptors in the heart and increases the
contractile force
c. activates alpha 1-receptors and causes dilation of blood vessels;
activates beta-receptors in the heart and decreases the contractile
